An intriguing battery (materials) play, although execution is the key
Blackstone Resources should soon start benefiting, in cash-flow terms, from the operational start of its mining, smelting and trading assets. While the group, in 2019, made an interesting bet in…
Extra-financing to increase visibility
Crossject announced it has issued zero-coupon convertible bonds (€5.7m) at 92% of their nominal value, maturing on 31 December 2021, convertible at the lowest price between €2.30 and an average…
When cement goes green too
Cementir has announced a €100m additional green investment, and cost-cutting strategies in the ‘Industrial Plan 2022’ during the 9M 2019 results. To promote profitable sustainability, the investment is aimed at…
Green capex should drive EPS higher
In our opinion, the 300bp EBITDA margin improvement by 2022 as well as the back-ended green capex should drive EPS higher as soon as 2020, compared to our previous assumptions….
Reassuring end of year update
Dietswell released a positive end of year update. While the environment remains positive in offshore wind, the group has also signed several significant contracts in oil & gas. It seems…
A €2.6m non-dilutive issue
Crossject has announced it has obtained a €2.6m non-dilutive financing from IdVector Science and Technology, a European investor specialising in long-term non-dilutive financing of technology. The financing takes the form…
Another robust quarterly showing
Q3 revenues are showing robustness even though some of Protective Films’ end markets (Chargeurs’ main business) remain in the slow lane. Q3 sales up 1.7% lfl confirm management’s earlier observation…
Priority to organic growth
Overall, 9m results were in line with our expectations. Cementir has decided to invest in itself rather than going for a transformative acquisition. Following this earnings release, we expect to…
The challenge remains intact
Cash payments are dropping, pushing down the terminals and authorisations divisions, while the software activity is trying to offset these, mostly helped by EasyOrder and Magellan. Top and bottom lines…
Cooperation agreement with the US Department of Defense
Crossject announced yesterday it had signed a Cooperative Research and Development Agreement (CRADA) with the US Department of Defense. This cooperation agreement consists, in our understanding, in developing Zeneo Midazolam…